Biotech Stocks to Keep an Eye-On (Dendreon Corporation, Human Genome Sciences, Celgene Corporation, Amgen, Inc.)
Biotech Stocks to Keep an Eye-On
(EMAILWIRE.COM, September 02, 2010 ) New York, NY-Dendreon Corporation (NASDAQ:DNDN) soared 6.70% to $38.24 on over 3.49 million shares after The Centers for Medicare and Medicaid Services said that it has called a meeting to consider the currently available evidence regarding the impact of prostate cancer vaccine Provenge on patients with metastatic prostate cancer.
Today, the stock opened at $37.10 and was trading within the range of $37.01-$38.49. The volumes were moderate today at 3.49 million shares as compared to its daily average volume of 3.72 million shares. At today`s closing market price, the market capitalization of the stock stood at $5.51 billion. So far this year, the stock advanced almost 44%.
To get FREE Stock newsletters, please sign up at http://www.stocksgonewild.com
Human Genome Sciences (NASDAQ:HGSI) gained 1.65% to $29.55 on over 3.93 million shares. The stock has a 52-week range of $17.30-$34.49. The volumes were high today at 3.93 million shares as compared to its daily average volume of 2.66 million shares.
Human Genome Sciences is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: BENLYSTA for systemic lupus erythematosus (SLE), ZALBIN for chronic hepatitis C, and raxibacumab for inhalation anthrax.
Celgene Corporation (NASDAQ:CELG) rose 2.45% to $52.73 on over 3.23 million shares. The volumes moderate today at 3.23 million shares as compared to its daily average volume of 3.45 million shares.
Over the past 52-weeks, the stock traded within the range of $48.02-$65.79.
Amgen, Inc. (NASDAQ:AMGN) surged 3.04% to $52.59 on over 4.78 million shares. After opening the trade at $51.61, the stock today traded within the range of $51.28-$52.75. At today`s closing market price, the market capitalization of the stock stood at $50.41 billion.
About http://www.stocksgonewild.com
StocksGoneWild.com strives in finding penny stocks that are poised to breakout! We actively search every resource on the market to find undervalued stocks with the potential to make both huge short and long-term gains.
Explosive Gains of 100-1000%! Email Alerts before the Stock Breaks Out! The Best Fundamental and Technical Analysis of the Markets at Your Fingertips
DISCLAIMER
This is not an offer to buy or sell securities. Information or opinions are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Neither Stocksgonewild.com nor any of its employees, affiliates, subsidiaries or family members are registered investment advisors or registered stock brokers and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.
Today, the stock opened at $37.10 and was trading within the range of $37.01-$38.49. The volumes were moderate today at 3.49 million shares as compared to its daily average volume of 3.72 million shares. At today`s closing market price, the market capitalization of the stock stood at $5.51 billion. So far this year, the stock advanced almost 44%.
To get FREE Stock newsletters, please sign up at http://www.stocksgonewild.com
Human Genome Sciences (NASDAQ:HGSI) gained 1.65% to $29.55 on over 3.93 million shares. The stock has a 52-week range of $17.30-$34.49. The volumes were high today at 3.93 million shares as compared to its daily average volume of 2.66 million shares.
Human Genome Sciences is a commercially focused biopharmaceutical company. The Company has three products in late-stage clinical development: BENLYSTA for systemic lupus erythematosus (SLE), ZALBIN for chronic hepatitis C, and raxibacumab for inhalation anthrax.
Celgene Corporation (NASDAQ:CELG) rose 2.45% to $52.73 on over 3.23 million shares. The volumes moderate today at 3.23 million shares as compared to its daily average volume of 3.45 million shares.
Over the past 52-weeks, the stock traded within the range of $48.02-$65.79.
Amgen, Inc. (NASDAQ:AMGN) surged 3.04% to $52.59 on over 4.78 million shares. After opening the trade at $51.61, the stock today traded within the range of $51.28-$52.75. At today`s closing market price, the market capitalization of the stock stood at $50.41 billion.
About http://www.stocksgonewild.com
StocksGoneWild.com strives in finding penny stocks that are poised to breakout! We actively search every resource on the market to find undervalued stocks with the potential to make both huge short and long-term gains.
Explosive Gains of 100-1000%! Email Alerts before the Stock Breaks Out! The Best Fundamental and Technical Analysis of the Markets at Your Fingertips
DISCLAIMER
This is not an offer to buy or sell securities. Information or opinions are presented solely for informative purposes, and are not intended nor should they be construed as investment advice. Neither Stocksgonewild.com nor any of its employees, affiliates, subsidiaries or family members are registered investment advisors or registered stock brokers and shall not be liable for any direct, indirect, incidental, special or consequential damages arising out of or resulting from the use or inability to use this site, including but not limited to damages for the loss of capital, funds, profits, use, data, or any and all other possible damages, even if such party has been advised of the possibility of such damages resulting from the use of this site and all information contained on this site.
Contact Information:
Stocksgonewild.com
Editor
Tel: 732-229-0668
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
Stocksgonewild.com
Editor
Tel: 732-229-0668
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




